跳至主要内容
临床试验/ISRCTN67373128
ISRCTN67373128进行中(未招募)未知

In vivo effects of chronic administration of a Phaseolus vulgaris extract, containing alpha-amylase inhibitor and agglutinin, on glucometabolic status and the hunger-satiety circuit in subjects with severe obesity

Istituto Auxologico Italiano0 个研究点目标入组 208 人开始时间: 2021年5月20日最近更新:
适应症

试验速览

阶段
未知
状态
进行中(未招募)
入组人数
208

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. Obesity (BMI =35 kg/m²) with or without comorbidities
  • 2. 18 to 65 years of age
  • 3. Dysglycemia, altered fasting glycemia or insulin resistance (HOMA index >2.5)
  • 4. Possibility to be followed in the follow up at Auxologico Via Ariosto (Milan)
  • 5. Negative swab for COVID-19 at enlistment

排除标准

  • 1. Type 1 and 2 diabetes in treatment
  • 2. Previous operations of bariatric surgery
  • 3. Psychiatric illness
  • 4. Inflammatory bowel disease
  • 5. Untreated thyroid
  • 6. Past or present history of malignant neoplasia

研究者

相似试验